- ICH GCP
- US Clinical Trials Registry
- Researchers
- Italy
- Lymphoma, B-Cell
Medical specialists from Italy tagged as investigators in clinical trials studying Lymphoma, B-Cell
Total 182 results
-
Adalberto IbaticiSeen in:
- Milan, Incyte Biosciences Italy S.r.l
Trials:- NCT06299553 (Principal Investigator)
Conditions: -
Agostino Tafuri, MDSeen in:
- Roma, AO Sant Andrea, Ematologia
- Roma, AO Sant'Andrea - Ematologia
- Roma, Azienda Ospedaliero-Universitaria Sant Andrea, UOC Ematologia
- Roma, UOC Ematologia - A.O. Sant'Andrea
Trials:- NCT04442412 (Principal Investigator)
- NCT05819528 (Principal Investigator)
- NCT05929222 (Principal Investigator)
- NCT05934084 (Principal Investigator)
- NCT05966233 (Principal Investigator)
Conditions: -
ALBERTO FABBRISeen in:
- Milan, Incyte Biosciences Italy S.r.l
- SI, Siena, AOU Senese - U.O.C. Ematologia
- Siena, AOU Senese, U.O.C. Ematologia
- Siena, Azienda Ospedaliero-Universitaria Senese
- Siena, Siena - Azienda Ospedaliera Universitaria Senese
- Siena, U.O.C. Ematologia - A.O.U. Senese
Trials:- NCT02227251 (Principal Investigator)
- NCT05524298 (Principal Investigator)
- NCT06299553 (Principal Investigator)
- NCT03495960 (Principal Investigator)
- NCT04882475 (Principal Investigator)
- NCT05966233 (Principal Investigator)
- NCT06113081 (Principal Investigator)
Conditions:- Diffuse Large B-cell Lymphoma;
- Low Grade Non-Hodgkin's Lymphoma, Adult;
- DLBCL - Diffuse Large B Cell Lymphoma;
- Primary Central Nervous System Lymphoma;
- Mantle Cell Lymphoma;
- Diffuse Large B-cell Lymphoma Recurrent;
- Diffuse Large B Cell Lymphoma Refractory;
- Cutaneous T Cell Lymphoma;
- Cutaneous T-Cell Lymphoma/Mycosis Fungoides;
- Cutaneous T-Cell Lymphoma/Sezary Syndrome
-
Alessandra MicozziSeen in:
- (rm), Roma, Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia
Trials:- NCT03804372 (Sub-Investigator)
Conditions: -
Alessandra Tucci, MDSeen in:
- Brescia, ASST Spedali Civili di Brescia
- Brescia, ASST Spedali Civili di Brescia - Ematologia
- Brescia, ASST Spedali Civili di Brescia, Ematologia
- Brescia, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- Brescia, S.C. Ematologia - ASST Spedali Civili
- Brescia, SC Ematologia, Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
Trials:- NCT05058404 (Principal Investigator)
- NCT03495960 (Principal Investigator)
- NCT04128072 (Principal Investigator)
- NCT04646395 (Principal Investigator)
- NCT05966233 (Principal Investigator)
- NCT05977673 (Principal Investigator)
- NCT06113081 (Principal Investigator)
Conditions:- Follicular Lymphoma;
- Primary Central Nervous System Lymphoma;
- Stage IB-IIB Cutaneous T-Cell Lymphoma;
- Marginal Zone Lymphoma;
- Diffuse Large B-cell Lymphoma Recurrent;
- Diffuse Large B Cell Lymphoma Refractory;
- Hodgkin Lymphoma;
- Cutaneous T Cell Lymphoma;
- Cutaneous T-Cell Lymphoma/Mycosis Fungoides;
- Cutaneous T-Cell Lymphoma/Sezary Syndrome
-
Alessandro Allegra, MDSeen in:
- Messina, AOU G. Martino - U.O.C. Ematologia
Trials:- NCT05934084 (Principal Investigator)
-
Alessandro MorottiSeen in:
- Turin, AOU San Luigi Gonzaga - Orbassano University of Turin
Trials:- NCT04332822 (Principal Investigator)
Conditions: -
Alessandro PintoSeen in:
- Napoli, Azienda Ospedaliera Univeristaria Federico II di Napoli
Trials:- NCT04332822 (Principal Investigator)
Conditions: -
Alessia Bari, MDSeen in:
- Modena, A.O. Universitaria Policlinico Di Modena
- Modena, Azienda Ospedaliero-Universitaria Policlinico di Modena - U.O. Oncologia
- Modena, Azienda Ospedaliero-Universitaria Policlinico di Modena, U.O. Oncologia
Trials:- NCT02390869 (Principal Investigator)
- NCT05816850 (Principal Investigator)
- NCT05934084 (Principal Investigator)
-
Alice Di RoccoSeen in:
- Milan, Incyte Biosciences Italy S.r.l
- Roma, Dipartimento di Medicina Traslazionale e di Precisione - Policlinico Umberto I - Università "La Sapienza" Istituto Ematologia
- Roma, Policlinico Umberto I - Universitа "La Sapienza" - Istituto Ematologia -Dipartimento di Medicina Traslazionale e di Precisione
- Roma, Policlinico Umberto I - Universitа "La Sapienza", Istituto Ematologia -Dipartimento di Medicina Traslazionale e di Precisione
- Roma, Università La Sapienza Ematologia
Trials:- NCT05249959 (Principal Investigator)
- NCT06299553 (Principal Investigator)
- NCT04442412 (Principal Investigator)
- NCT04882475 (Principal Investigator)
- NCT05966233 (Principal Investigator)
-
Andrea BernardelliSeen in:
- Milan, Incyte Biosciences Italy S.r.l
Trials:- NCT06299553 (Principal Investigator)
Conditions: -
Andrès FerreriSeen in:
- Lombardia, Milano, Ospedale San Raffaele
- Milan, Incyte Biosciences Italy S.r.l
- Milan, Milano, IRCCS Ospedale San Raffaele
- Milano, Istituto Scientifico San Raffaele - Unitа Linfomi - Dipartimento Oncoematologia
- Milano, Istituto Scientifico San Raffaele, Unità Linfomi - Dipartimento Oncoematologia
- Milano, Istituto Scientifico San Raffaele, Unitа Linfomi - Dipartimento Oncoematologia
- Milano, Ospedale San Raffaele S.r.l., Unitа Linfomi - Dipartimento Oncoematologia
- Milano, Unitа Linfomi - Dipartimento Oncoematologia, Istituto Scientifico San Raffaele
- Segrate, IRCCS San Raffaele Scientific Institute
Trials:- NCT04332822 (Principal Investigator)
- NCT04662255 (Principal Investigator)
- NCT05524298 (Principal Investigator)
- NCT06299553 (Principal Investigator)
- NCT05058404 (Principal Investigator)
- NCT03495960 (Principal Investigator)
- NCT04915248 (Principal Investigator)
- NCT05929222 (Principal Investigator)
- NCT05966233 (Principal Investigator)
Conditions:- Diffuse Large B Cell Lymphoma;
- DLBCL;
- Lymphoma, Mantle-Cell;
- Low Grade Non-Hodgkin's Lymphoma, Adult;
- DLBCL - Diffuse Large B Cell Lymphoma;
- Follicular Lymphoma;
- Primary Central Nervous System Lymphoma;
- Plasmablastic Lymphoma;
- Diffuse Large B-cell Lymphoma Recurrent;
- Diffuse Large B Cell Lymphoma Refractory
-
Andres Jose Maria FerreriSeen in:
- Other, Milano, IRCCS Ospedale San Raffaele
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Angelo Andreini, MDSeen in:
- Verona, AOU Integrata di Verona, U.O. Ematologia
Trials:- NCT05966233 (Principal Investigator)
-
Anna Dodero, MDSeen in:
- Milan, Fondazione IRCCS Istituto Nazionale Tumori
Trials:- NCT06339255 (Sub-Investigator)
-
Anna Giulia Zizzari, MDSeen in:
- Roma, Policlinico Tor Vergata - Ematologia
Trials:- NCT05934084 (Principal Investigator)
-
Anna Lia Molinari, MDSeen in:
- Rimini, Ospedale Degli Infermi
- Rimini, Ospedale degli Infermi di Rimini - U.O. di Ematologia
- Rimini, UO Ematologia - Ospedale degli Infermi
Trials:- NCT04442412 (Principal Investigator)
- NCT03552003 (Principal Investigator)
- NCT02371161 (Principal Investigator)
-
Anna Marina Liberati, MDSeen in:
- TR, Terni, A.O. S. Maria di Terni
- TR, Terni, A.O. Santa Maria di Terni
- Terni, A.O. S. Maria di Terni - S.C. Oncoematologia
- Terni, Univ. Perugia Sede Terni - Oncoematologia
Trials:- NCT05058404 (Principal Investigator)
- NCT02390869 (Principal Investigator)
- NCT04442412 (Principal Investigator)
- NCT04333524 (Principal Investigator)
- NCT05819528 (Principal Investigator)
-
Anna Merli, MDSeen in:
- Other, Rimini, AUSL della Romagna Ospedale Infermi
- Other, Rimini, Ospedale Degli Infermi
- Rimini, AUSL della Romagna - Presidio Ospedaliero Rimini - Ospedale "Infermi"
- Rimini, Ospedale degli Infermi di Rimini - U.O. di Ematologia
Trials:- NCT05058404 (Principal Investigator)
- NCT03495960 (Principal Investigator)
- NCT04404283 (Principal Investigator)
-
Anna Tonso, MDSeen in:
- Biella, Ospedale Degli Infermi
Trials:- NCT01009970 (Principal Investigator)
Conditions: -
Annalisa Arcari, MDSeen in:
- Piacenza, Ospedale Guglielmo da Saliceto - U.O.Ematologia
- Piacenza, Ospedale Guglielmo da Saliceto, U.O. Ematologia
- Piacenza, Ospedale Guglielmo da Saliceto, U.O.Ematologia
- Piacenza, Piacenza
Trials:- NCT05058404 (Principal Investigator)
- NCT03495960 (Principal Investigator)
- NCT04882475 (Principal Investigator)
- NCT05816850 (Principal Investigator)
- NCT05934084 (Principal Investigator)
- NCT05966233 (Principal Investigator)
-
Annalisa Chiappella, MDSeen in:
- Milan, Fondazione IRCCS Istituto Nazionale Tumori
Trials:- NCT06339255 (Sub-Investigator)
-
Annalisa ChiarenzaSeen in:
- Catania, A.O.U. Policlinico G.Rodolico - S. Marco
- Catania, Azienda Ospedaliera Universitaria Policlinico - S. Marco - UOC di Emtologia
- Catania, U.O.C. di Ematologia - Azienda Ospedaliera Universitaria Policlinico - Rodolico S. Marco
- Milan, Incyte Biosciences Italy S.r.l
Trials:- NCT04666038 (Principal Investigator)
- NCT05524298 (Principal Investigator)
- NCT06299553 (Principal Investigator)
- NCT05934084 (Sub-Investigator)
-
Annarita Conconi, MDSeen in:
- BI, Ponderano, Ospedale Degli Infermi
- Biella, Biella - Ospedale Degli Infermi - S.C. Oncologia
- Biella, Nuovo Ospedale degli Infermi - SSD Ematologia
- Biella, Nuovo Ospedale degli Infermi, SSD Ematologia
- Biella, Ospedale degli Infermi di Biella, SSD Ematologia
- Biella, SOS Ematologia Divisione Medicina Interna Ospedale degli Infermi
- IT, Biella, Nuovo Ospedale degli Infermi, SSD Ematologia
Trials:- NCT05058404 (Principal Investigator)
- NCT03697512 (Principal Investigator)
- NCT02390869 (Principal Investigator)
- NCT04442412 (Principal Investigator)
- NCT04333524 (Principal Investigator)
- NCT05816850 (Principal Investigator)
- NCT05929222 (Principal Investigator)
- NCT06070961 (Principal Investigator)
-
Antonello PintoSeen in:
- Napoli, Istituto Nazionale Tumori "Fondazione Pascale" Napoli
Trials:- NCT04332822 (Principal Investigator)
Conditions: -
Antonello Sica, MDSeen in:
- Napoli, AOU Università degli Studi della Campania Luigi Vanvitelli - Oncologia Medica ed Ematologia
- Napoli, AOU Universitа degli Studi della Campania Luigi Vanvitelli - Oncologia Medica ed Ematologia
- Napoli, Napoli - AOU Universitа degli Studi della Campania Luigi Vanvitelli - Oncologia Medica ed Ematologia
Trials:- NCT05058404 (Principal Investigator)
- NCT04442412 (Principal Investigator)
- NCT03552003 (Principal Investigator)
Clinical Trials on Lymphoma, B-Cell
-
Iksuda Therapeutics Ltd.RecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non-Hodgkin LymphomaAustralia, Canada, United States
-
University of ChicagoMerck Sharp & Dohme LLCRecruitingLymphoma | Lymphoma, B-Cell | B Cell Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell LymphomaUnited States
-
Curocell Inc.RecruitingHigh-grade B-cell Lymphoma | Diffuse Large B-cell Lymphoma (DLBCL) | Primary Mediastinal Large B-Cell Lymphoma (PMBCL) | Transformed Follicular Lymphoma (TFL) | Refractory Large B-cell Lymphoma | Relapsed Large B-cell LymphomaKorea, Republic of
-
Nathan DenlingerBristol-Myers SquibbRecruitingB-Cell Non-Hodgkin Lymphoma-Recurrent | Diffuse Large B-Cell Lymphoma-Recurrent | Follicular Lymphoma-Recurrent | High Grade B-Cell Lymphoma-Recurrent | Primary Mediastinal Large B-Cell Lymphoma-Recurrent | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Recurrent and other conditionsUnited States
-
Massachusetts General HospitalVarian Medical SystemsRecruitingLymphoma, B-Cell | Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Lymphoma | High-grade B-cell Lymphoma | Relapsed Cancer | Mediastinal Large B-cell LymphomaUnited States
-
Dana-Farber Cancer InstituteBayer; AbbVieActive, not recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Weill Medical College of Cornell UniversityEpizyme, Inc.; American Society of Clinical Oncology; Applebaum FoundationRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-Cell LymphomaUnited States
-
British Columbia Cancer AgencyNot yet recruitingB-cell Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-Cell Leukemia | B-cell Acute Lymphoblastic Leukemia | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | High-grade B-cell LymphomaCanada
-
AstraZenecaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | B-cell Non Hodgkin LymphomaKorea, Republic of, United States, Japan, Taiwan, Australia
-
MEI Pharma, Inc.TerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone B Cell Lymphoma | High Grade Non-Hodgkin's LymphomaUnited States, Switzerland